SC
HSTO

Steven Cohen’s Histogen Inc. Common Stock HSTO Stock Holding History

Steven Cohen’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,642
Closed -$946K – 894
2015
Q4 		$946K Buy
+1,642
New +$1.15M 0.01% 614

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Steven Cohen's HSTO Position: Q1 2016 in Review

Steven Cohen sold out of Histogen Inc. Common Stock (HSTO) in Q1 2016, closing a stake of 1,642 shares — an estimated $946K sold.

Steven Cohen first reported a position in HSTO in Q4 2015 and held it in 1 quarter. The position peaked at $946K in Q4 2015. 32 funds tracked by Wall St. Rank hold HSTO as of Q1 2016.

  • Steven Cohen reported no remaining Histogen Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • Steven Cohen sold 1,642 Histogen Inc. Common Stock shares in Q1 2016, an estimated $946K.
  • Steven Cohen first reported a position in Histogen Inc. Common Stock in Q4 2015 and held it in 1 quarter.
  • Steven Cohen's Histogen Inc. Common Stock position peaked at $946K in Q4 2015.
  • 32 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q1 2016.

Based on Point72 Asset Management's 13F filing for Q1 2016, filed 16 May 2016.